Novo Nordisk
NVO
#86
Rank
ยฃ152.08 B
Marketcap
ยฃ34.31
Share price
-2.72%
Change (1 day)
-29.12%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): ยฃ18.61 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are ยฃ51.37 Billion. In 2025 the company made an earning of ยฃ15.70 Billion, an increase over its 2024 earnings that were of ยฃ14.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ18.61 B18.56%
2025 ยฃ15.70 B6.28%
2024 ยฃ14.77 B28.01%
2023 ยฃ11.54 B57.81%
2022 ยฃ7.31 B5.24%
2021 ยฃ6.94 B12.38%
2020 ยฃ6.18 B13.11%
2019 ยฃ5.46 B-3.45%
2018 ยฃ5.66 B1.88%
2017 ยฃ5.55 B4.3%
2016 ยฃ5.32 B10.32%
2015 ยฃ4.83 B7.47%
2014 ยฃ4.49 B3.4%
2013 ยฃ4.34 B19.09%
2012 ยฃ3.65 B15.58%
2011 ยฃ3.15 B16.58%
2010 ยฃ2.70 B25.66%
2009 ยฃ2.15 B10.68%
2008 ยฃ1.94 B55.82%
2007 ยฃ1.25 B7.02%
2006 ยฃ1.16 B19.05%
2005 ยฃ0.98 B10.55%
2004 ยฃ0.88 B
2002 ยฃ0.61 B-14.39%
2001 ยฃ0.72 B-52.82%
2000 ยฃ1.53 B250%
1999 ยฃ0.43 B31.21%
1998 ยฃ0.33 B34.31%
1997 ยฃ0.24 B11.46%
1996 ยฃ0.22 B9.03%
1995 ยฃ0.20 B-3.15%
1994 ยฃ0.21 B-0.67%
1993 ยฃ0.21 B45.38%
1992 ยฃ0.14 B-13.81%
1991 ยฃ0.16 B37.12%
1990 ยฃ0.12 B-0.79%
1989 ยฃ0.12 B26.2%
1988 ยฃ98.61 M24.97%
1987 ยฃ78.91 M-0.9%
1986 ยฃ79.63 M-7.78%
1985 ยฃ86.35 M24.87%
1984 ยฃ69.15 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ7.93 B-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.31 B 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ5.73 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
ยฃ7.18 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA